Synlogic (STU:MIN) Ending Cash Position: €12.24 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:MIN Synlogic Inc STU:MIN
30 GF Score
Price €3.63
! 1 Warning Sign
View Full Analysis

What is Synlogic Ending Cash Position?

Synlogic STU:MIN 30 Ending Cash Position is €12.24 Mil as of Mar. 2026. GuruFocus rates STU:MIN with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Synlogic's Ending Cash Position for the quarter that ended in Mar. 2026 was €12.24 Mil.

Synlogic's quarterly Ending Cash Position declined from Sep. 2025 (€13.33 Mil) to Dec. 2025 (€12.57 Mil) and declined from Dec. 2025 (€12.57 Mil) to Mar. 2026 (€12.24 Mil).

Synlogic's annual Ending Cash Position declined from Dec. 2023 (€22.98 Mil) to Dec. 2024 (€18.06 Mil) and declined from Dec. 2024 (€18.06 Mil) to Dec. 2025 (€12.57 Mil).

Synlogic Ending Cash Position Related Terms

Synlogic Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Synlogic's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synlogic Ending Cash Position Chart

Synlogic Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.52 16.01 22.98 18.06 12.57

Synlogic Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.02 14.81 13.33 12.57 12.24
STU:MIN
30GF Score
Synlogic Inc STU:MIN
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synlogic Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Synlogic's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=16.149+-3.58
=12.57

Synlogic's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=12.731+-0.487
=12.24

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €12.24 Mil mean?
Synlogic (STU:MIN) has a Ending Cash Position of €12.24 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Synlogic and its competitors.
Is Synlogic's Ending Cash Position too high?
Synlogic's current Ending Cash Position is €12.24 Mil. Overall, Synlogic has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Synlogic's Ending Cash Position compare to APRE and MTVA?
Synlogic's Ending Cash Position of €12.24 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Synlogic and its competitors. Synlogic's current Ending Cash Position is €12.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synlogic stock overvalued right now?
Synlogic (STU:MIN) has a current Ending Cash Position of €12.24 Mil. The current Ending Cash Position is €12.24 Mil. Synlogic's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Synlogic (STU:MIN), the current Ending Cash Position is €12.24 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Synlogic Business Description

Other Exchanges SYBX:USA0A8U:UK
Address PO Box 30, Winchester, MA, USA, 01890
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. The pipeline drug candidates includes: labafenogene marselecobac (SYNB1934); SYNB1353 Classical Homocystinuria (HCU); SYNB8802 Enteric Hyperoxaluria; and SYNB2081 Gout. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one operating segment: Discovery and development of Synthetic Biotics.
30GF Score

Get the complete analysis for STU:MIN

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.63
Price